🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseSemaglutide liver fat quantification — MRI-PDFF data from multiple trials Page 5

Semaglutide liver fat quantification — MRI-PDFF data from multiple trials

MASHdoc_SA Tue, Jun 2, 2026 at 9:22 AM 22 replies 672 viewsPage 5 of 5
MariaRD
Member
823
4,567
Jun 2024
New Mexico
Jun 3, 2026 at 8:25 PM#21
raj_cambridge said:
Say what you would expect to see if you were wrong, before you look.

Worth saying that the confident version of this is more useful to the person writing it than to the person reading it.

29 2Dr.NutriCornell, pam_stl, wei_SG and 26 others
Reply Quote Save Share Report
RunnerRach
Member
467
2,123
Aug 2024
Boston, MA
Jun 4, 2026 at 3:48 AM#22
raj_cambridge said:
Say what you would expect to see if you were wrong, before you look.

That is right, and it stops being right at the edges. The general case is well behaved; the interesting cases in this thread are all at the boundary where the general case breaks.

30 3MikeKY_noInsulin, Dr.RaviCardio, jennifer_SEA and 27 others
Reply Quote Save Share Report
PharmacoVig_BOS
Senior Member
1,567
8,901
Feb 2024
Boston, MA
Jun 4, 2026 at 11:11 AM#23
raj_cambridge said:
Say what you would expect to see if you were wrong, before you look.

Saving this. It is the first explanation that did not require me to already understand it. Adding it to my notes with a link back to this thread.

31 4DataDave, Dr.GutHealth, amsterdam_pete and 28 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
Dr.Martinez
Medical Advisor
3,891
28,456
Nov 2023
Boston, MA
Online
Jun 4, 2026 at 6:34 PM#24

Clinical perspective, offered as context rather than as advice. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

Worth separating that from liver and MASH, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

I would rather be corrected than agreed with, if it comes to it.

32 5Dr.SurgeonPGH, rachel_ABQ, traveltech_sara and 29 others
Reply Quote Save Share Report
LabKate
Senior Member
2,678
11,234
Jan 2024
Oregon
Jun 5, 2026 at 1:57 AM#25
Dr.Martinez said:
It helps to say which part of this you are uncertain about.

Mine went the same way, slower.

Last edited: Jun 5, 2026 at 4:57 AM
33 6labquiet_amy, emily_PDX, Dr.SleepRoch and 30 others
Reply Quote Save Share Report
1345

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register